Kamada Ltd (KMDA) Dividend History

Kamada Ltd (KMDA) is an Israel-based biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived protein therapeutics for the treatment of various medical conditions, such as rare diseases and inflammatory disorders. The company's products are based on plasma proteins, including Alpha-1 antitrypsin, used for treatment and research purposes. Kamada leverages its proprietary manufacturing platform to produce plasma-derived therapies and expand its portfolio in the biopharmaceutical space.

Website: https://www.kamada.com

Dividend History

Pay Date Amount Ex Dividend Date Record Date
April 07, 2025 $0.20 03/17/2025 03/17/2025

Company News

  • Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025

    Kamada Ltd., a global biopharmaceutical company, announced that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2024, on March 5, 2025. The company will host an investor conference call to discuss the results.

    GlobeNewswire Inc.
  • Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems. HUB Cyber Security Ltd. (NASDAQ: HUBC) shares jumped 60.5% to $0.3836. Phoenix Motor Inc. (NASDAQ: PEV) climbed 48% to $1.48. Phoenix Motor said its EdisonFuture subsidiary launched new Proton Exchange Membrane (PEM) solutions for green hydrogen products and production. Maris-Tech Ltd. (NASDAQ: MTEK) shares climbed 21.1% to $1.2110. Maris-Tech announced its participation in the upcoming Milipol Paris 2023 at the Paris Norde Villepinte exhibition. Senstar Technologies Ltd. (NASDAQ: SNT) surged 20.5% to $1.35. AERWINS Technologies Inc. (NASDAQ: AWIN) gained 19.5% to $0.1688. AERWINS Technologies said its board approved the establishment of a United States subsidiary in Los Angeles, California to pursue the redesign of its XTURISMO Ltd Edition prototype 1 hoverbike. Windtree Therapeutics, Inc. (NASDAQ: WINT) climbed 13.3% to $1.3601. Jin Medical International Ltd. (NASDAQ: ZJYL) rose 16% to $15.93. T2 Biosystems, Inc. (NASDAQ: TTOO) climbed 17% to $0.3075. Vivakor, Inc. (NASDAQ: VIVK) gained 15.6% to $0.96. Singularity Future Technology Ltd. (NASDAQ: SGLY) jumped 15.3% to $0.68. National Western Life Group, Inc. (NASDAQ: NWLI) climbed 13.8% to $474.69 after the company inked a definitive merger deal with Prosperity Life Group for about $1.9 billion in an all-cash transaction. U.S. Energy Corp. (NASDAQ:

    Benzinga
    Featured Companies: AAOI BMY FBYD FEMY HOLO HUBC LAC LMT MBLY MTEK NNOX NOC PGY PRZO RPTX SGLY SLNG SNT SPRU TNGX TSBX TSLA USEG VIVK WHLR WINT WNW ZJYL
  • These Israeli pharmaceutical stocks are down in the wake of Hamas attack

    Shares of Israeli pharmaceutical giant Teva are down Monday following Hamas's attack over the weekend.

    MarketWatch
    Featured Companies: CGEN PLX
  • Zymeworks (ZYME) Stock Up 29% in Three Months: Here's Why

    Zymeworks (ZYME) recently entered a collaboration with Jazz Pharmaceuticals (JAZZ) for its lead pipeline candidate. This has been a significant catalyst for the stock.

    Zacks Investment Research
    Featured Companies: JAZZ ZYME
Page data last updated 07/24/2025 00:50:50 UTC